TrademarkDir
IMBRIA
LIVE

Serial Number

88985327

Owner

Imbria Pharmaceuticals, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Nov 14, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMBRIA Trademark

Serial Number: 88985327 • Registration: 7469123

IMBRIA is a trademark filed by Imbria Pharmaceuticals, Inc. on November 14, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Imbria Pharmaceuticals, Inc. (5 trademarks)

265 Franklin Street, Suite 1702
Boston, MA 02110

Entity Type: 03

Trademark Details

Filing Date

November 14, 2018

Registration Date

August 6, 2024

Published for Opposition

February 28, 2023

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 28, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 28, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2024 CRFA
ASSIGNED TO LIE
Jun 20, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 4, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 4, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 8, 2024 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Nov 30, 2023 SUPC
DIVISIONAL PROCESSING COMPLETE
Nov 30, 2023 DPCC
SOU EXTENSION 1 GRANTED
Nov 30, 2023 EX1G
RESPONSE TO ITU OFFICE ACTION ENTERED
Nov 21, 2023 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2023 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Nov 20, 2023 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 30, 2023 AITU
USE AMENDMENT FILED
Oct 25, 2023 IUAF
DIVISIONAL REQUEST RECEIVED
Oct 25, 2023 DRRR
SOU EXTENSION 1 FILED
Oct 25, 2023 EXT1
TEAS REQUEST TO DIVIDE RECEIVED
Oct 25, 2023 ERTD
SOU TEAS EXTENSION RECEIVED
Oct 25, 2023 EEXT
TEAS STATEMENT OF USE RECEIVED
Oct 25, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 25, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2023 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 18, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 27, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 22, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 12, 2021 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 24, 2021 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 6, 2020 RCSC
ASSIGNED TO LIE
Aug 5, 2020 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 30, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 24, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 24, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jun 24, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2019 CRFA
ASSIGNED TO LIE
Jun 13, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 7, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 20, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 20, 2019 GNSL
SUSPENSION LETTER WRITTEN
Feb 20, 2019 CNSL
ASSIGNED TO EXAMINER
Feb 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2018 NWOS
NEW APPLICATION ENTERED
Nov 17, 2018 NWAP

Related Trademarks

More from this Owner

IMBRIA PHARMACEUTICALS

IMBRIA PHARMACEUTICALS

IMBRIA PHARMACEUTICALS logo

IMBRIA PHARMACEUTICALS

IMBRIA

IMBRIA

IMBRIA

IMBRIA

IMBRIA

IMBRIA

IMBRIA

IMBRIA